V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005300 | 320003631 | 1.55 | 54.8 | Adjuvant (A) | 2014-02-02 | 2014-03-11 | Trial Unspecified | Y | null | 320017125 | TRIAL |
| 320005301 | 320003631 | 1.56 | 57 | Palliative (P) | 2013-08-28 | 2013-09-04 | Trial Unspecified | Y | null | 320017125 | TRIAL |
| 320005302 | 320003632 | 1.55 | 96.85 | Palliative (P) | 2014-07-26 | 2014-08-24 | GEMCARBO | null | N | 320017154 | GEMCARBO |
| 320005303 | 320003633 | 1.72 | 81.15 | Palliative (P) | 2014-12-05 | 2014-12-25 | Cetuximab 7 day (>Cycle 2) | N | N | 320017159 | CETUXIMAB |
| 320005304 | 320003634 | 1.67 | 58.5 | Curative (C) | 2016-12-22 | 2017-03-02 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320017164 | CISPLATIN + RT |
| 320005305 | 320003635 | 1.55 | 59.6 | Palliative (P) | 2016-12-11 | 2016-12-11 | Liposomal Doxorubicin (Caelyx) | N | N | 320017164 | LIPOSOMAL DOXORUBICIN |
| 320005306 | 320006626 | 1.59 | 60.4 | Curative (C) | null | 2016-07-11 | Cisplatin | null | null | 320017178 | CISPLATIN |
| 320005307 | 320006626 | 1.66 | 67 | Palliative (P) | 2017-06-26 | 2017-07-11 | Liposomal Doxorubicin 50mg/m2 | N | N | 320017178 | LIPOSOMAL DOXORUBICIN |
| 320005308 | 320003637 | 1.59 | 60 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-04 | GemCarbo Days 1+8 | 2 | N | 320017206 | GEMCARBO |
| 320005309 | 320003638 | 1.74 | 64.2 | null | 2017-12-16 | 2017-12-26 | Liposomal Doxorubicin 40mg/m2 | N | N | 320017209 | LIPOSOMAL DOXORUBICIN |
| 320005310 | 320003638 | 1.71 | 74.4 | Curative (C) | 2016-07-16 | 2016-07-24 | null | 2 | N | 320017209 | NOT MATCHED |
| 320005311 | 320007294 | 1.64 | 73 | null | null | 2016-01-17 | Liposomal Doxorubicin (Caelyx) | N | N | 320017230 | LIPOSOMAL DOXORUBICIN |
| 320005312 | 320003640 | 1.8 | 76.1 | Palliative (P) | 2017-07-30 | 2017-08-01 | CISPLATIN + FLUOROURACIL | 02 | N | 320017233 | CISPLATIN + FLUOROURACIL |
| 320005313 | 320003641 | 1.67 | 57.4 | Palliative (P) | 2017-08-14 | 2018-02-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320017236 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005314 | 320003642 | null | 59 | Adjuvant (A) | 2017-09-16 | 2017-09-17 | Cetuximab 7 day (>Cycle 2) | 02 | N | 320017245 | CETUXIMAB |
| 320005315 | 320003643 | 1.6 | 77.7 | Palliative (P) | 2015-06-05 | 2015-06-05 | EW EuroEwing 2012 Arm B VDC | 01 | N | 320017254 | TRIAL |
| 320005316 | 320006629 | null | 69 | Palliative (P) | 2013-11-22 | 2013-12-17 | Cisplatin | N | N | 320017263 | CISPLATIN |
| 320005317 | 320003646 | 1.73 | null | Palliative (P) | 2018-10-11 | 2018-10-11 | EW EuroEwing 2012 Arm B VDC | null | Y | 320017272 | TRIAL |
| 320005318 | 320003647 | 1.56 | 72.3 | Adjuvant (A) | 2016-11-21 | 2016-12-17 | CISPLATIN + RT | Y | N | 320017276 | CISPLATIN + RT |
| 320005319 | 320003648 | 1.67 | 92.3 | Curative (C) | 2017-02-26 | 2017-03-19 | Cisplatin + Radiotherapy | 2 | N | 320017289 | CISPLATIN + RT |
| 320005320 | 320003648 | 1.63 | 81 | Palliative (P) | 2015-02-10 | 2015-02-26 | CISPLATIN + FLUOROURACIL | N | N | 320017289 | CISPLATIN + FLUOROURACIL |
| 320005324 | 320003653 | 1.5 | null | Palliative (P) | 2017-05-11 | 2017-05-15 | Carboplatin + Liposomal Doxorubicin | N | null | 320017355 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005325 | 320003654 | 0 | 71.2 | Curative (C) | 2013-03-30 | 2013-04-04 | Cisplatin + Radiotherapy | 02 | N | 320017371 | CISPLATIN + RT |
| 320005326 | 320003655 | 1.7 | 89.1 | Curative (C) | 2016-08-08 | 2016-08-29 | Cisplatin + Radiotherapy | N | N | 320017374 | CISPLATIN + RT |
| 320005327 | 320003656 | 1.78 | 53.6 | Curative (C) | 2016-11-10 | 2016-12-26 | Cisplatin + Radiotherapy | 1 | N | 320017391 | CISPLATIN + RT |
| 320005328 | 320003657 | null | 89.9 | Palliative (P) | 2017-01-20 | 2017-01-23 | CISPLATIN + FLUOROURACIL | Y | null | 320017403 | CISPLATIN + FLUOROURACIL |
| 320005329 | 320003660 | 1.68 | 76 | Neo-adjuvant (N) | 2017-12-07 | 2017-12-07 | null | 2 | null | 320017404 | NOT MATCHED |
| 320005330 | 320003661 | 1.77 | 72.5 | Adjuvant (A) | 2014-11-15 | 2015-05-10 | CARBOPLATIN + GEMCITABINE | 02 | Y | 320017420 | GEMCARBO |
| 320005331 | 320003663 | 1.72 | null | Neo-adjuvant (N) | 2015-03-17 | 2015-11-26 | GEMCARBO | N | N | 320017423 | GEMCARBO |
| 320005332 | 320003664 | 1.65 | 69.5 | Palliative (P) | 2017-11-03 | 2017-11-25 | CARBOPLATIN + GEMCITABINE | 02 | N | 320017423 | GEMCARBO |
| 320005333 | 320007085 | null | 66 | Palliative (P) | 2015-03-26 | 2015-03-31 | Carboplatin + Liposomal Doxorubicin | null | N | 320017443 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005334 | 320006632 | 1.66 | 13.5 | Palliative (P) | 2017-03-20 | 2017-07-14 | Liposomal Doxorubicin 40mg/m2 | N | Y | 320017455 | LIPOSOMAL DOXORUBICIN |
| 320005335 | 320003667 | 1.68 | 97.2 | Adjuvant (A) | null | 2019-01-19 | GemCarbo Days 1+8 | N | N | 320017455 | GEMCARBO |
| 320005336 | 320003667 | 1.65 | 62 | Palliative (P) | 2015-08-17 | 2015-08-17 | CARBOPLATIN + GEMCITABINE | 02 | N | 320017455 | GEMCARBO |
| 320005337 | 320003668 | 1.82 | null | Palliative (P) | null | 2015-04-04 | CISPLATIN + FLUOROURACIL | N | N | 320017480 | CISPLATIN + FLUOROURACIL |
| 320005338 | 320005675 | 1.59 | null | Palliative (P) | 2017-03-22 | 2017-03-28 | Cetuximab 7 day (>Cycle 2) | Y | null | 320017480 | CETUXIMAB |
| 320005339 | 320005676 | 1.77 | null | Adjuvant (A) | 2017-10-30 | 2017-10-31 | CARBOPLATIN + GEMCITABINE | 2 | N | 320017493 | GEMCARBO |
| 320005340 | 320005676 | 1.68 | 89.9 | Palliative (P) | 2017-12-18 | 2017-12-24 | Carboplatin + Liposomal Doxorubicin | 02 | N | 320017493 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005341 | 320005676 | 1.6 | 81 | Palliative (P) | 2017-06-14 | 2017-06-14 | Trial Unspecified | N | N | 320017493 | TRIAL |
| 320005342 | 320003670 | null | 83.6 | Palliative (P) | 2015-05-07 | 2015-05-08 | Liposomal Doxorubicin (Caelyx) | null | null | 320017510 | LIPOSOMAL DOXORUBICIN |
| 320005343 | 320003671 | 1.72 | 77 | Palliative (P) | 2016-06-15 | 2016-07-04 | Liposomal Doxorubicin 50mg/m2 | N | N | 320017521 | LIPOSOMAL DOXORUBICIN |
| 320005344 | 320003673 | 1.7 | null | Palliative (P) | 2016-07-14 | 2016-08-11 | LUX TRIAL | N | N | 320017523 | TRIAL |
| 320005345 | 320003674 | 1.65 | 83 | Palliative (P) | 2016-07-11 | 2016-07-13 | Liposomal Doxorubicin 40mg/m2 | 02 | Y | 320017526 | LIPOSOMAL DOXORUBICIN |
| 320005346 | 320003674 | 1.75 | 54.9 | Palliative (P) | 2016-10-07 | 2016-10-07 | Carboplatin + Liposomal Doxorubicin | N | N | 320017526 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005347 | 320003675 | 1.57 | 114.2 | Palliative (P) | 2016-02-20 | 2016-02-28 | Carboplatin + Liposomal Doxorubicin | null | null | 320017559 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005348 | 320003676 | null | 70 | Palliative (P) | 2016-07-15 | 2016-07-20 | Cisplatin +Fluorouracil (3 wk) | N | N | 320017603 | CISPLATIN + FLUOROURACIL |
| 320005349 | 320003676 | 1.77 | 51.9 | Palliative (P) | 2015-05-30 | 2015-05-30 | GemCarbo Days 1+8 | null | N | 320017603 | GEMCARBO |
| 320005350 | 320003678 | 1.6 | 57 | Curative (C) | null | 2014-05-06 | GEMCARBO | N | Y | 320017615 | GEMCARBO |
| 320005351 | 320003679 | 1.59 | 67 | Neo-adjuvant (N) | 2015-07-01 | 2015-09-26 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 320017640 | POUT TRIAL |
| 320005352 | 320006638 | 1.67 | null | Adjuvant (A) | null | 2015-11-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 320017653 | NIVOLUMAB |